持续性膀胱冲洗装置市场－全球产业规模、份额、趋势、机会、预测：按产品、最终用户、地区和竞争对手划分，2021-2031年

全球持续膀胱冲洗装置市场预计将从 2025 年的 14.9 亿美元成长到 2031 年的 19.1 亿美元，复合年增长率为 4.23%。

这些专用医疗系统对于确保膀胱稳定供应无菌生理食盐水至关重要，其主要作用是预防血栓形成，并在经尿道前列腺切除术等泌尿系统手术后维持导尿管通畅性。市场成长的根本驱动因素是全球泌尿系统疾病（例如良性前列腺增生）盛行率的上升，这些疾病需要频繁的手术干预；以及老年人口的增长，老年人尤其容易受到需要灌注治疗才能安全术后恢復的疾病的影响。

近期疾病发病率统计数据有力地支持了对这些临床解决方案的需求。美国癌症协会估计，2024年美国将新增83,190例膀胱癌病例，凸显了有效术后管理工具的迫切需求。然而，由于导尿管相关尿道感染的风险，市场面临许多挑战。严格的感染控制要求以及医院获得性感染可能引发的併发症构成了一项重大挑战，可能会限制这些冲洗装置在医疗机构中的长期使用。

市场驱动因素

市场成长的主要驱动力是老年人口的快速成长，因为老化与良性前列腺增生（BPH）之间存在密切关联。随着男性年龄的增长，罹患BPH的几率显着增加，导致需要进行经尿道前列腺切除术（TURP）等手术的人数上升。这些手术需要持续膀胱灌注，以预防血尿併发症并维持导尿管的通畅。这一人口趋势保证了对灌注系统的稳定需求，2024年7月AUANews的一篇报导指出“BPH影响着大约60%的60岁以上男性和几乎所有80岁以上的男性”，形成了大规模的泌尿系统护理患者群体。

同时，由于诊断率的提高和疫情后手术延误的消除，泌尿系统手术量增加，也推动了市场成长。膀胱癌和摄护腺疾病等疾病手术量的增加，直接导致医院冲洗液和导尿管系统的日常使用量增加。例如，英国前列腺癌协会在2024年4月发布的报告显示，与疫情前相比，2022年3月至2023年2月期间，英格兰的泌尿系统系统癌症治疗数量增加了8.5%。手术量的激增正在推动製造商的收入成长。科乐普公司2024年的财务表现也显示，其介入泌尿外科部门实现了5%的内部成长，这主要得益于男性健康和内视镜泌尿系统领域的持续需求。

市场挑战

持续性膀胱冲洗装置全球市场的主要障碍是导尿管相关尿道感染（CAUTI）的持续威胁。由于持续冲洗依赖留置导尿管，长期使用会促进细菌定植，增加患者的感染风险。这迫使医疗机构实施严格的「拔管」通讯协定和合理使用抗生素的计划，要求儘早拔除导尿管。这些临床实践直接限制了冲洗治疗的持续时间，导致一次性冲洗装置和无菌冲洗液的使用量减少。这对製造商的持续收入产生了负面影响。

此外，治疗医院感染所带来的经济负担迫使医疗机构管理者限制侵入性技术的使用。医院往往需要为可预防的感染疾病承担自付费用，而长期使用体外循环设备也会带来经济风险。根据2024年APIC的数据，导管相关感染疾病占所有医疗相关感染疾病的30%以上，这迫使医疗机构尽量减少对这些设备的依赖，以避免高昂的感染控製成本。这正在减缓市场成长。

市场趋势

智慧感测器在即时血流监测中的应用，满足了精准液体管理和自动血栓检测的需求，显着推动了市场发展。这些基于感测器的系统持续分析颜色和流量等流出指标，并自动调节灌注速率，从而防止导管阻塞和膀胱过度充盈，同时最大限度地减少手动调节带来的误差。 2024年10月发表于《泌尿系统杂誌》的一项研究证实了该技术的临床价值。接受整合式感测器设备治疗的患者平均住院时间为3.3天，显着短于标准治疗的3.6天，凸显了这些智慧解决方案的高效性和安全性优势。

同时，对严格的感染控制通讯协定和运作效率的需求正推动一次性冲洗装置的日益普及。医疗机构正转向完全一次性系统，以消除重复使用部件带来的交叉感染风险，并透过简化复杂的再处理流程来简化术后工作流程。这一转变在该领域强劲的市场趋势中显而易见。例如，Ambu A/S 的 2023/24 年度报告显示，其内视镜解决方案业务（包括一次性泌尿系统）的有机收入增长率为 19.7%，显示市场对一次性介入技术的需求强劲。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球持续性膀胱冲洗装置市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品细分（Foley 三腔导尿管（硅胶导尿管、乳胶导尿管）、冲洗袋、配件（冲洗器、滚轮夹、排放袋））
  • 依最终使用者（医院/诊所、门诊护理中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美持续性膀胱冲洗装置市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲持续膀胱冲洗装置市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区持续膀胱冲洗装置市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲持续膀胱冲洗装置的市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲持续膀胱冲洗装置的市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球持续性膀胱冲洗装置市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Sterimed Group
• Angiplast pvt. ltd.
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• BACTIGUARD AB
• VOGT MEDICAL
• CR Bard
• Coloplast Corp
• Hospital Equipment Manufacturing Company
• Baxter Internationals

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Continuous Bladder Irrigation Devices Market is projected to expand from USD 1.49 billion in 2025 to USD 1.91 billion by 2031, reflecting a compound annual growth rate of 4.23%. These specialized medical systems are essential for delivering a steady stream of sterile saline into the bladder, primarily to prevent clot retention and ensure catheter patency after urological surgeries like Transurethral Resection of the Prostate. Market growth is fundamentally driven by the rising global prevalence of urological disorders, such as Benign Prostatic Hyperplasia, which demand frequent surgical interventions, alongside an expanding geriatric population that is particularly vulnerable to conditions requiring postoperative irrigation for safe recovery.

Recent statistics on disease incidence strongly underpin the demand for these clinical solutions, with the American Cancer Society estimating 83,190 new bladder cancer diagnoses in the United States for 2024, highlighting the critical need for effective postoperative management tools. However, the market faces significant hurdles due to the risk of catheter-associated urinary tract infections. Strict infection control requirements and the potential for hospital-acquired complications present a major challenge that may restrict the prolonged usage of these irrigation devices within healthcare facilities.

Market Driver

A primary factor driving market growth is the rapid expansion of the geriatric population, given the strong correlation between aging and Benign Prostatic Hyperplasia (BPH). As men age, the likelihood of prostate enlargement increases significantly, often necessitating surgeries like Transurethral Resection of the Prostate (TURP), where continuous bladder irrigation is mandatory to prevent hematuria complications and maintain catheter flow. This demographic trend ensures a steady baseline demand for irrigation systems, a reality supported by an AUANews article from July 2024 stating that BPH affects approximately 60% of men in their 60s and nearly all men aged 80 and above, creating a large patient base needing urological care.

Simultaneously, the market is bolstered by an increasing volume of urological procedures, fueled by better diagnostic rates and the resolution of post-pandemic surgical backlogs. The rise in surgeries for conditions like bladder cancer and prostate disorders directly increases the daily usage of irrigation fluids and catheter systems in hospitals; for example, Prostate Cancer UK reported in April 2024 that urological cancer treatments in England rose by 8.5% between March 2022 and February 2023 compared to pre-pandemic levels. This surge in procedural activity translates into revenue growth for manufacturers, as seen in Coloplast's 2024 financial results, where their Interventional Urology division achieved 5% organic growth due to sustained demand in men's health and endourology.

Market Challenge

The major obstacle hindering the Global Continuous Bladder Irrigation Devices Market is the persistent threat of catheter-associated urinary tract infections (CAUTIs). Because continuous irrigation relies on indwelling catheters, extended usage facilitates bacterial colonization and heightens patient vulnerability, prompting healthcare institutions to enforce strict "catheter-off" protocols and antibiotic stewardship programs that require early device removal. These clinical practices directly limit the duration of irrigation therapy, subsequently reducing the volume of disposable sets and sterile fluids used, which negatively impacts manufacturers' recurring revenue streams.

Additionally, the financial burden of treating hospital-acquired conditions compels medical administrators to restrict the use of invasive technologies. Hospitals often face non-reimbursement penalties for preventable infections, making prolonged irrigation device usage a financial liability. Data from the Association for Professionals in Infection Control and Epidemiology in 2024 indicated that catheter-associated infections accounted for over 30% of all healthcare-associated infections, forcing providers to minimize reliance on these devices to avoid significant infection management costs, thereby slowing market expansion.

Market Trends

The integration of smart sensors for real-time flow monitoring is significantly advancing the market by fulfilling the need for precise fluid management and automated clot detection. These sensor-based systems continuously analyze outflow metrics such as color and volume to automatically adjust irrigation rates, helping to prevent catheter blockage and bladder overdistension while minimizing errors associated with manual regulation. A study published in the Urology Journal in October 2024 demonstrated the clinical value of this technology, showing that patients treated with sensor-integrated devices had a significantly shorter hospital stay of 3.3 days compared to 3.6 days for standard care, highlighting the efficiency and safety benefits of these intelligent solutions.

Concurrently, there is a growing trend toward the adoption of single-use and disposable irrigation sets, driven by strict infection control protocols and a desire for operational efficiency. Healthcare facilities are increasingly moving to fully disposable systems to eliminate cross-contamination risks linked to reusable components and to simplify postoperative workflows by removing complex reprocessing logistics. This shift is evidenced by strong market performance in this sector, such as Ambu A/S reporting 19.7% organic revenue growth in its Endoscopy Solutions division-which includes single-use urology devices-in their 2023/24 annual report, signaling robust demand for disposable interventional technologies.

Key Market Players

• Sterimed Group
• Angiplast pvt. ltd.
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• BACTIGUARD AB
• VOGT MEDICAL
• C. R. Bard
• Coloplast Corp
• Hospital Equipment Manufacturing Company
• Baxter Internationals

Report Scope

In this report, the Global Continuous Bladder Irrigation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Bladder Irrigation Devices Market, By Product

• Foley 3 Way Catheters(Silicone Catheters, Latex Catheters)
• Irrigation Bags
• Accessories (Irrigation Set, Roller Clamp, Outlet Bags)

Continuous Bladder Irrigation Devices Market, By End user

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Continuous Bladder Irrigation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Continuous Bladder Irrigation Devices Market.

Available Customizations:

Global Continuous Bladder Irrigation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Bladder Irrigation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Foley 3 Way Catheters(Silicone Catheters, Latex Catheters), Irrigation Bags, Accessories (Irrigation Set, Roller Clamp, Outlet Bags))
  • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Continuous Bladder Irrigation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End user
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End user
  • 6.3.2. Canada Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End user
  • 6.3.3. Mexico Continuous Bladder Irrigation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End user

7. Europe Continuous Bladder Irrigation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End user
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End user
  • 7.3.2. France Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End user
  • 7.3.3. United Kingdom Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End user
  • 7.3.4. Italy Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End user
  • 7.3.5. Spain Continuous Bladder Irrigation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End user

8. Asia Pacific Continuous Bladder Irrigation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End user
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End user
  • 8.3.2. India Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End user
  • 8.3.3. Japan Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End user
  • 8.3.4. South Korea Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End user
  • 8.3.5. Australia Continuous Bladder Irrigation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End user

9. Middle East & Africa Continuous Bladder Irrigation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End user
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End user
  • 9.3.2. UAE Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End user
  • 9.3.3. South Africa Continuous Bladder Irrigation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End user

10. South America Continuous Bladder Irrigation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End user
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End user
  • 10.3.2. Colombia Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End user
  • 10.3.3. Argentina Continuous Bladder Irrigation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Continuous Bladder Irrigation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sterimed Group
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Angiplast pvt. ltd.
• 15.3. Advin Health Care
• 15.4. AdvaCare Pharma
• 15.5. Teleflex Incorporated
• 15.6. BACTIGUARD AB
• 15.7. VOGT MEDICAL
• 15.8. C. R. Bard
• 15.9. Coloplast Corp
• 15.10. Hospital Equipment Manufacturing Company
• 15.11. Baxter Internationals

16. Strategic Recommendations

17. About Us & Disclaimer